“A Clinical Case of Successful Treatment of HER2-Low Disseminated Breast Cancer with Trastuzumab Deruxtecan” (2023) Voprosy onkologii, 69(4), pp. 757–760. doi:10.37469/0507-3758-2023-69-4-757-760.